Our approach identified multiple AFR-specific protein-altering variants in the APOL gene family implicated in kidney disease risk, including a stop-gain variant in APOL3 that increases the risk of CKD primarily in persons carrying 1 APOL1 G1/G2 risk allele. This evidence concerns the gene APOL1 and chronic kidney disease.